Displaying 25 - 36 of 141
Metabolism, Alcohol & Toxicity

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity

Metabolic Comorbidities Unmasked -  Redefining MASLD/MASH Impact

Webcasts
View
Metabolism, Alcohol & Toxicity

Shedding light on genomic, metabolic, and phenotypic effects of essential phospholipids on HepaRG

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and closing remarks

Webcasts
View
Metabolism, Alcohol & Toxicity

GSK: Meet the Experts - Genetic architecture of Steatotic Liver Disease (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

GSK: Unlocking the genetic architecture of Steatotic Liver Disease. A new paradigm in patient management (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: Personalised management of MASH (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

AKH Inc., Advancing Knowledge in Healthcare: A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best ...

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: Updates on the essence of MASH (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Boehringer Ingelheim: A patient journey in MASH: Advancing care through collaborative innovation (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Opella: MASLD's impact on metabolic health and quality of life – new evidence (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Rising to the Need to Improve Diagnosis in the Era of Disease-specific Therapy

Webcasts
View
Displaying 25 - 36 of 141